Interview: Bill Oldham: CEO Oldham Global
About the Author: HCN News Team
The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Related Posts
Latest News
Willow Biosciences Reports Q3 2024
LOS ANGELES- Willow Biosciences Inc., a biotechnology firm specializing in the industrial production of functional ingredients, has reported its financial results for the third quarter of 2024. The company achieved record revenue of $1.7 million ...
UK Explores Raising THC Limits for Industrial Hemp to Boost Farming Prospects
LOS ANGELES- The United Kingdom is evaluating a proposal to increase the permissible tetrahydrocannabinol (THC) content in industrial hemp from 0.2% to 0.3%, aligning with standards in the European Union and the United States. This ...
FDA Approves Cannabis Trial for Treating PTSD in Veterans
LOS ANGELES- The U.S. Food and Drug Administration (FDA) has approved a clinical trial investigating the use of smoked cannabis as a treatment for post-traumatic stress disorder (PTSD) in military veterans. The study, led by ...
